390 related articles for article (PubMed ID: 16459490)
1. Piracetam--an old drug with novel properties?
Winnicka K; Tomasiak M; Bielawska A
Acta Pol Pharm; 2005; 62(5):405-9. PubMed ID: 16459490
[TBL] [Abstract][Full Text] [Related]
2. Piracetam: novelty in a unique mode of action.
Müller WE; Eckert GP; Eckert A
Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():2-9. PubMed ID: 10338102
[TBL] [Abstract][Full Text] [Related]
3. [Does treatment with piracetam in stroke patients with aphasia make sense?].
Schmidtke K
Dtsch Med Wochenschr; 2002 Dec; 127(49):2636. PubMed ID: 12469280
[No Abstract] [Full Text] [Related]
4. Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles.
Genton P; Van Vleymen B
Epileptic Disord; 2000 Jun; 2(2):99-105. PubMed ID: 10954241
[TBL] [Abstract][Full Text] [Related]
5. Piracetam and platelets--a review of laboratory and clinical data.
Evers S; Grotemeyer KH
Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():44-8. PubMed ID: 10338108
[TBL] [Abstract][Full Text] [Related]
6. Piracetam: a novel therapy for autism?
Paczynski M
J Autism Dev Disord; 1997 Oct; 27(5):628-30. PubMed ID: 9403377
[No Abstract] [Full Text] [Related]
7. The role of piracetam in the treatment of acute and chronic aphasia.
Huber W
Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():38-43. PubMed ID: 10338107
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of the nootropic drugs].
Boĭko SS; Vitskova GIu; Zherdev VP
Eksp Klin Farmakol; 1997; 60(6):62-70. PubMed ID: 9460604
[No Abstract] [Full Text] [Related]
9. [Effect of piracetam on urea-induced myoclonus in rats].
Nanri M; Yamamoto A; Matsuura N
Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):45-50. PubMed ID: 11062861
[TBL] [Abstract][Full Text] [Related]
10. Piracetam improves cognitive performance by restoring neurochemical deficits of the aged rat brain.
Scheuer K; Rostock A; Bartsch R; Müller WE
Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():10-6. PubMed ID: 10338103
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of nootropic potential of Ocimum sanctum Linn. in mice.
Joshi H; Parle M
Indian J Exp Biol; 2006 Feb; 44(2):133-6. PubMed ID: 16480180
[TBL] [Abstract][Full Text] [Related]
12. Antimyoclonic efficacy of piracetam in idiopathic generalized epilepsy.
Khani YA; Andermann F; Andermann E
Epilepsia; 2005 Jul; 46(7):1145-6. PubMed ID: 16026569
[TBL] [Abstract][Full Text] [Related]
13. Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?
Güngör L; Terzi M; Onar MK
Brain Lang; 2011 Apr; 117(1):23-7. PubMed ID: 21227483
[TBL] [Abstract][Full Text] [Related]
14. Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte D-glucose transport.
Naftalin RJ; Cunningham P; Afzal-Ahmed I
Br J Pharmacol; 2004 Jun; 142(3):594-608. PubMed ID: 15148255
[TBL] [Abstract][Full Text] [Related]
15. [Experimental and clinical rationale for complex treatment of mental disorders in clean-up workers of the Chernobyl nuclear plant accident].
Neznamov GG; Koshelev VV; Voronina TA; Trofimov SS
Eksp Klin Farmakol; 2002; 65(2):12-6. PubMed ID: 12109283
[TBL] [Abstract][Full Text] [Related]
16. Effects of piracetam on behavior and memory in adult zebrafish.
Grossman L; Stewart A; Gaikwad S; Utterback E; Wu N; Dileo J; Frank K; Hart P; Howard H; Kalueff AV
Brain Res Bull; 2011 Apr; 85(1-2):58-63. PubMed ID: 21371538
[TBL] [Abstract][Full Text] [Related]
17. [Effect of piracetam on the conditional reflex memory under probable reinforcement conditions].
Riabchikova NA; Tushmalova NA; Pragina LL; Shul'govskiĭ VV
Eksp Klin Farmakol; 2001; 64(6):17-9. PubMed ID: 11871229
[TBL] [Abstract][Full Text] [Related]
18. Piracetam: a review of pharmacological properties and clinical uses.
Winblad B
CNS Drug Rev; 2005; 11(2):169-82. PubMed ID: 16007238
[TBL] [Abstract][Full Text] [Related]
19. [Effect of low doses of piracetam on conditional reflex memory in rats].
Tushmalova NA; Pragina LL; Inozemtsev AN; Gumargalieva KZ; Solov'ev AG; Burlakova EB
Biull Eksp Biol Med; 1995 Jul; 120(7):60-1. PubMed ID: 8527785
[No Abstract] [Full Text] [Related]
20. Piracetam-induced changes to membrane physical properties. A combined approach by 31P nuclear magnetic resonance and conformational analysis.
Peuvot J; Schanck A; Deleers M; Brasseur R
Biochem Pharmacol; 1995 Oct; 50(8):1129-34. PubMed ID: 7488225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
